compound semaglutide being discontinued FDA Warns on Certain Forms of Compounded are compounded semaglutide being discontinued

In drug development, in particular, advances require collaboration across multiple disciplines and organizations, including physicians, patient advocacy groups, research organizations, and patients themselves, among others

The added compounds may create new research questions, but they also move farther away from the evidence

Despite extensive research, some scientists classify curcumin as a pan-assay interference compound (PAIN), which challenges its validity as a metabolic panacea (IMPS) or as a suitable lead compound (Nelson et al., 2017)

Wang D-X, Yang Y, Huang X-S et al (2021) Pramipexole attenuates neuronal injury in Parkinsons disease by targeting miR-96 to activate BNIP3-mediated mitophagy